Thinking of joining a study?

Register your interest

Become a volunteer?

NCT06168019 | RECRUITING | Influenza

Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India
Sponsor:

Boston University

Brief Summary:

This study will be conducted as a prospective cohort study, enrolling all eligible women in their first trimester of pregnancy during a baseline visit during week 6-13 of pregnancy at Government Medical College Hospital, Nagpur. The Hospital provides primary, secondary, and tertiary care and the obstetric department delivers about 10,000 babies a year. The hypothesis is that co-infection of other respiratory viruses (ORV), particularly COVID-19 and Influenza increases the risk of adverse pregnancy outcomes in mothers and babies and could address the current standard of care in India to not vaccinate pregnant women during pregnancy, by either encouraging vaccination against both viruses before planning a pregnancy or during pregnancy based on global data supporting the safety of this strategy.

Condition or disease

Influenza

COVID-19

SARS-COV-2 Infection

Other Respiratory Viruses

Perinatal Morbidity

Infant Morbidity

Intervention/treatment

Exposures

Detailed Description:

All pregnant women enrolled in the study will receive standard of care throughout their pregnancy, labor and delivery and post-partum to discharge. Wherever possible, study visits will coincide with regular antenatal (ANC) care and blood draws will be added to standard blood draws during ANC, labor and delivery and postpartum care. Women will be counselled about procedure to reduce the risk of acquiring ORV during pregnancy. Since this study is observational, we do not anticipate any specific safety concerns with study interviews and procedures, but the investigators will monitor potential adverse events to determine if they are likely or possibly study related. PRIMARY OBJECTIVE: Determine the prevalence, incidence, and maximal severity of symptomatic or asymptomatic COVID-19 in pregnant women to day 42 postpartum/after miscarriage on maternal outcomes. Secondary analysis will evaluate whether influenza/Other Respiratory Viruses (ORV) infection or COVID-19 vaccination modifies or mediates this risk. SECONDARY OBJECTIVE: Determine the effect of maternal COVID-19 infection on the fetus and/or neonate during pregnancy through day 7 of life. Secondary analysis will focus on whether influenza/ORV or vaccination modifies, and pre-term birth mediates this risk. EXPLORATORY OBJECTIVE: Characterize patterns and trajectories of host response/ inflammatory biomarkers as potential mediators of COVID-19 ± Influenza and ORV infection on progression to severe illness in pregnant women/mothers admitted to Government Medical College hospital with COVID-19. Modifiers include COVID-19 , Influenza and other ORV vaccinations.

Study Type : OBSERVATIONAL
Estimated Enrollment : 10000 participants
Official Title : Influenza & COVID-19 Obstetric and Perinatal Epidemiology (ICOPE) Study in India
Actual Study Start Date : 2023-12-26
Estimated Primary Completion Date : 2028-06
Estimated Study Completion Date : 2028-06

Information not available for Arms and Intervention/treatment

Ages Eligible for Study: 18 Years to 50 Years
Sexes Eligible for Study: FEMALE
Criteria
Inclusion Criteria
  • Women aged 18 to 50 years registering for antenatal care (ANC) at Government Medical College Hospital (GMC) Nagpur, India
  • * Estimated Gestational Age at registration \<14 weeks based on ultrasound report at the baseline study visit;
  • * Intends to receive pregnancy, labor and delivery and neonatal care at GMC;
  • * Plans to live within the city limits of Nagpur throughout their pregnancy and labor and delivery to facilitate access to GMC for evaluation of ILI and COVID-19 symptoms;
  • * Willing to be contacted two times per week by call or text for ILI/ COVID-19 symptom screening and return to GMC for evaluation and an NP swab/evaluation if symptoms are reported;
  • * Willing to take temperature with the provided digital thermometer, and maintain a symptom diary after training;
  • * Willing to provide information on pregnancy and neonatal outcomes if care occurs outside GMC;
  • * Willing to permit venous blood draws on at least 4 timepoints --1) Baseline study visit, 2)28-34 weeks, 3) 37 weeks - prior to delivery and 4) after delivery;
  • * Willing to permit blood draws if hospitalized at GMC for COVID-19 infection;
  • * Willing to consent to participate in the study
Exclusion Criteria
  • * Anyone who is deemed to have limited decision-making capacity as defined by Boston University IRB i.e. Substantial impairment of cognitive functions (e.g. attention, comprehension, memory, and intellect), or conditions that might affect their cognitive functions.
  • * Anyone who is deemed to have limited capacity to consent as defined by Boston University Institutional Review Board (IRB) i.e. The ability to provide legally effective consent to enroll in a research study (AAHRPP definition).
Influenza & COVID-19 Obstetric and Perinatal Epidemiology Study in India

Location Details

NCT06168019

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

RECRUITING

United States, Massachusetts

Boston University School of Public Health, Global Health

Boston, Massachusetts, United States, 02118

RECRUITING

India,

Government. Medical College Hospital

Nagpur, India,